Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Quality of Life Research 8/2020

05-03-2020

Patient-reported outcomes in melanoma survivors at 1, 3 and 5 years post-diagnosis: a population-based cross-sectional study

Auteurs: Karolina Lisy, Julia Lai-Kwon, Andrew Ward, Shahneen Sandhu, Nadine A. Kasparian, Julie Winstanley, Frances Boyle, David Gyorki, Karen Lacey, Jim Bishop, Michael Jefford

Gepubliceerd in: Quality of Life Research | Uitgave 8/2020

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

There is a lack of population-based data describing patient reported outcomes (PROs) in melanoma survivors which could guide the development of interventions and resources. This study assessed overall quality of life (QoL), self-reported symptoms and unmet information needs in melanoma survivors 1, 3 or 5 years post-diagnosis.

Methods

A cross-sectional postal survey was conducted in Victoria, Australia, with eligible melanoma survivors identified from a population-based cancer registry. Patient-reported outcome measures included the EuroQoL 5-Dimension 5-Level (EQ-5D-5L), and self-reported symptoms, difficulties and information needs. Associations between demographic, disease and care-related factors and QoL were also assessed.

Results

A total of 476 melanoma survivors participated in the study (response rate 46.5%). Anxiety and depressive symptoms were more prevalent in survivors compared to the general population (30.7% vs 21.6%; p < 0.01). Fear of cancer recurrence (48.3%) and fear of cancer spreading (37.8%) were the most commonly reported symptom items, and approximately one in five melanoma survivors had unmet information needs related to psychological aspects of living with melanoma. Recurrent melanoma, living in a nursing home, chronic comorbidities, and melanoma diagnosed at > 2 mm thickness were associated with lower QoL.

Conclusion

A large proportion of melanoma survivors reported ongoing quality of life deficits, fear of cancer recurrence, as well as unmet information needs up to 5 years after diagnosis. Patients may benefit from tailored informational resources and interventions that address the psychological aspects of living with and beyond melanoma.

Met onderstaand(e) abonnement(en) heeft u direct toegang:

BSL Podotherapeut Totaal

Binnen de bundel kunt u gebruik maken van boeken, tijdschriften, e-learnings, web-tv's en uitlegvideo's. BSL Podotherapeut Totaal is overal toegankelijk; via uw PC, tablet of smartphone.

Literatuur
1.
go back to reference Australian Institute of Health and Welfare, Cancer in Australia 2017. Cancer series no. 101.Cat. no. CAN 100. 2017. AIHW: Canberra Australian Institute of Health and Welfare, Cancer in Australia 2017. Cancer series no. 101.Cat. no. CAN 100. 2017. AIHW: Canberra
2.
go back to reference Hamel, J.-F., et al. (2016). A systematic review examining factors influencing health related quality of life among melanoma cancer survivors. European Journal of Cancer, 69, 189–198. PubMedCrossRef Hamel, J.-F., et al. (2016). A systematic review examining factors influencing health related quality of life among melanoma cancer survivors. European Journal of Cancer, 69, 189–198. PubMedCrossRef
3.
go back to reference Beutel, M. E., et al. (2015). Depression, anxiety and quality of life in long-term survivors of malignant melanoma: A register-based cohort study. PLoS ONE, 10(1), e0116440. PubMedPubMedCentralCrossRef Beutel, M. E., et al. (2015). Depression, anxiety and quality of life in long-term survivors of malignant melanoma: A register-based cohort study. PLoS ONE, 10(1), e0116440. PubMedPubMedCentralCrossRef
4.
go back to reference Costa, D. S., et al. (2016). Psychometric properties of the Fear of Cancer Recurrence Inventory: An item response theory approach. Psychooncology, 25(7), 832–838. PubMedCrossRef Costa, D. S., et al. (2016). Psychometric properties of the Fear of Cancer Recurrence Inventory: An item response theory approach. Psychooncology, 25(7), 832–838. PubMedCrossRef
5.
go back to reference Kasparian, N. A., McLoone, J. K., & Butow, P. N. (2009). Psychological responses and coping strategies among patients with malignant melanoma: A systematic review of the literature. Archives of Dermatology, 145(12), 1415–1427. PubMedCrossRef Kasparian, N. A., McLoone, J. K., & Butow, P. N. (2009). Psychological responses and coping strategies among patients with malignant melanoma: A systematic review of the literature. Archives of Dermatology, 145(12), 1415–1427. PubMedCrossRef
6.
go back to reference Glaser, A. W., et al. (2013). Patient-reported outcomes of cancer survivors in England 1–5 years after diagnosis: A cross-sectional survey. British Medical Journal Open, 3(4), e002317. Glaser, A. W., et al. (2013). Patient-reported outcomes of cancer survivors in England 1–5 years after diagnosis: A cross-sectional survey. British Medical Journal Open, 3(4), e002317.
7.
go back to reference Jefford, M., et al. (2017). Patient-reported outcomes in cancer survivors: A population-wide cross-sectional study. Supportive Care in Cancer, 25, 3171–3179. PubMedCrossRef Jefford, M., et al. (2017). Patient-reported outcomes in cancer survivors: A population-wide cross-sectional study. Supportive Care in Cancer, 25, 3171–3179. PubMedCrossRef
10.
go back to reference Norman, R., Cronin, P., & Viney, R. (2013). A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states. Applied Health Economics and Health Policy, 11(3), 287–298. PubMedCrossRef Norman, R., Cronin, P., & Viney, R. (2013). A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states. Applied Health Economics and Health Policy, 11(3), 287–298. PubMedCrossRef
11.
go back to reference Lumley, T., Survey: Analysis of complex survey samples. R package version 3.30. 2014. Lumley, T., Survey: Analysis of complex survey samples. R package version 3.30. 2014.
12.
go back to reference Winstanley, J. B., et al. (2015). Cross-cultural development of a quality-of-life measure for patients with melanoma: Phase 3 testing of an EORTC Melanoma Module. Melanoma Research, 25(1), 47–58. PubMedCrossRef Winstanley, J. B., et al. (2015). Cross-cultural development of a quality-of-life measure for patients with melanoma: Phase 3 testing of an EORTC Melanoma Module. Melanoma Research, 25(1), 47–58. PubMedCrossRef
13.
go back to reference Winstanley, J. B., et al. (2013). What are the pertinent quality-of-life issues for melanoma cancer patients? Aiming for the development of a new module to accompany the EORTC core questionnaire. Melanoma Research, 23(2), 167–174. PubMedCrossRef Winstanley, J. B., et al. (2013). What are the pertinent quality-of-life issues for melanoma cancer patients? Aiming for the development of a new module to accompany the EORTC core questionnaire. Melanoma Research, 23(2), 167–174. PubMedCrossRef
14.
go back to reference Kasparian, N. A., et al. (2016). "Melanoma: Questions and answers." Development and evaluation of a psycho-educational resource for people with a history of melanoma. Supportive Care in Cancer, 24(12), 4849–4859. PubMedCrossRef Kasparian, N. A., et al. (2016). "Melanoma: Questions and answers." Development and evaluation of a psycho-educational resource for people with a history of melanoma. Supportive Care in Cancer, 24(12), 4849–4859. PubMedCrossRef
15.
go back to reference Dieng, M., et al. (2016). Psychoeducational intervention to reduce fear of cancer recurrence in people at high risk of developing another primary melanoma: Results of a randomized controlled trial. Journal of Clinical Oncology, 34(36), 4405–4414. PubMedCrossRef Dieng, M., et al. (2016). Psychoeducational intervention to reduce fear of cancer recurrence in people at high risk of developing another primary melanoma: Results of a randomized controlled trial. Journal of Clinical Oncology, 34(36), 4405–4414. PubMedCrossRef
16.
go back to reference McLoone, J., et al. (2012). When the risks are high: Psychological adjustment among melanoma survivors at high risk of developing new primary disease. Qualitative Health Research, 22(8), 1102–1113. PubMedCrossRef McLoone, J., et al. (2012). When the risks are high: Psychological adjustment among melanoma survivors at high risk of developing new primary disease. Qualitative Health Research, 22(8), 1102–1113. PubMedCrossRef
17.
go back to reference Vogel, R. I., et al. (2017). Comparison of quality of life among long-term melanoma survivors and non-melanoma controls: A cross-sectional study. Quality of Life Research, 26(7), 1761–1766. PubMedPubMedCentralCrossRef Vogel, R. I., et al. (2017). Comparison of quality of life among long-term melanoma survivors and non-melanoma controls: A cross-sectional study. Quality of Life Research, 26(7), 1761–1766. PubMedPubMedCentralCrossRef
18.
go back to reference Holterhues, C., et al. (2011). Impact of melanoma on patients' lives among 562 survivors: A Dutch population-based study. Archives of Dermatology, 147(2), 177–185. PubMedCrossRef Holterhues, C., et al. (2011). Impact of melanoma on patients' lives among 562 survivors: A Dutch population-based study. Archives of Dermatology, 147(2), 177–185. PubMedCrossRef
19.
go back to reference Branstrom, R., et al. (2010). Predictors of sun protection behaviors and severe sunburn in an international online study. Cancer Epidemiology, Biomarkers & Prevention, 19(9), 2199–2210. CrossRef Branstrom, R., et al. (2010). Predictors of sun protection behaviors and severe sunburn in an international online study. Cancer Epidemiology, Biomarkers & Prevention, 19(9), 2199–2210. CrossRef
20.
go back to reference Lacey, K., et al. (2016). Presentations to general practice before a cancer diagnosis in Victoria: A cross-sectional survey. Medical Journal of Australia, 205(2), 66–71. PubMedCrossRef Lacey, K., et al. (2016). Presentations to general practice before a cancer diagnosis in Victoria: A cross-sectional survey. Medical Journal of Australia, 205(2), 66–71. PubMedCrossRef
21.
go back to reference Carey, M., et al. (2012). How well are we meeting haematological cancer survivors' preferences for involvement in treatment decision making? Patient Education and Counseling, 88(1), 87–92. PubMedCrossRef Carey, M., et al. (2012). How well are we meeting haematological cancer survivors' preferences for involvement in treatment decision making? Patient Education and Counseling, 88(1), 87–92. PubMedCrossRef
22.
Metagegevens
Titel
Patient-reported outcomes in melanoma survivors at 1, 3 and 5 years post-diagnosis: a population-based cross-sectional study
Auteurs
Karolina Lisy
Julia Lai-Kwon
Andrew Ward
Shahneen Sandhu
Nadine A. Kasparian
Julie Winstanley
Frances Boyle
David Gyorki
Karen Lacey
Jim Bishop
Michael Jefford
Publicatiedatum
05-03-2020
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 8/2020
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-020-02464-y